- Home
- MRNA vs SWKS Comparison
MRNA vs SWKS Comparison
Compare MRNA & SWKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRNA
- SWKS
- Stock Information
- Founded
- MRNA 2010
- SWKS 1962
- Country
- MRNA United States
- SWKS United States
- Employees
- MRNA 5800
- SWKS N/A
- Industry
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- SWKS Semiconductors
- Sector
- MRNA Health Care
- SWKS Technology
- Exchange
- MRNA Nasdaq
- SWKS Nasdaq
- Market Cap
- MRNA 9.2B
- SWKS 11.6B
- IPO Year
- MRNA 2018
- SWKS 1968
- Fundamental
- Price
- MRNA $23.83
- SWKS $69.15
- Analyst Decision
- MRNA Hold
- SWKS Hold
- Analyst Count
- MRNA 15
- SWKS 19
- Target Price
- MRNA $37.15
- SWKS $83.06
- AVG Volume (30 Days)
- MRNA 11.9M
- SWKS 3.5M
- Earning Date
- MRNA 11-06-2025
- SWKS 11-04-2025
- Dividend Yield
- MRNA N/A
- SWKS 4.02%
- EPS Growth
- MRNA N/A
- SWKS N/A
- EPS
- MRNA N/A
- SWKS 3.08
- Revenue
- MRNA $2,232,000,000.00
- SWKS $4,086,900,000.00
- Revenue This Year
- MRNA N/A
- SWKS N/A
- Revenue Next Year
- MRNA $10.38
- SWKS $7.15
- P/E Ratio
- MRNA N/A
- SWKS $22.92
- Revenue Growth
- MRNA N/A
- SWKS N/A
- 52 Week Low
- MRNA $23.15
- SWKS $47.93
- 52 Week High
- MRNA $56.70
- SWKS $95.46
- Technical
- Relative Strength Index (RSI)
- MRNA 41.63
- SWKS 37.70
- Support Level
- MRNA $23.48
- SWKS $73.06
- Resistance Level
- MRNA $25.56
- SWKS $90.90
- Average True Range (ATR)
- MRNA 1.41
- SWKS 3.45
- MACD
- MRNA -0.35
- SWKS -0.76
- Stochastic Oscillator
- MRNA 7.95
- SWKS 0.80
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About SWKS Skyworks Solutions Inc.
Skyworks Solutions produces semiconductors for wireless handsets and other devices that are used to enable wireless connectivity. Its main products include power amplifiers, filters, switches, and integrated front-end modules that support wireless transmissions. Skyworks' customers are mostly large smartphone manufacturers, but the firm also has a growing presence in nonhandset applications such as wireless routers, medical devices, and automobiles.